ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

Richard Bloch, advocate for patient information services, dead at 78.

July 30, 2004

NIGMS Forms Bioinformatics, Computational Bio Center.

May 25, 2001

FY99 Appropriations: Congress Tells NCI To Fund More Research In Prostate Cancer

October 30, 1998

First Clinical Guidelines On Ductal Lavage Published

March 29, 2002

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

June 11, 2014